Jack Barkin

5.6k citations

92 papers · 3.9k indexed · 1 hit paper · h-index 34

Urology top 0.05%
- Urinary Bladder and Prostate Research 57
- Urological Disorders and Treatments 11
Rheumatology top 0.5%
- Pelvic floor disorders treatments 27
Pulmonary and Respiratory Medicine top 1%
- Prostate Cancer Diagnosis and Treatment 39
- Prostate Cancer Treatment and Research 14
Endocrinology, Diabetes and Metabolism top 1%
- Hormonal and reproductive studies 27
Psychiatry and Mental health top 5%
Epidemiology
- Urinary Tract Infections Management 15
Surgery
- Bladder and Urothelial Cancer Treatments 10

Co-authors: Claus G. Roehrborn Paul Siami Betsy Morrill Ronaldo Damião Francesco Montorsi Kim Major‐Walker R. Paul Gagnier Indrani Nandy
Cited by: Urology Rheumatology Pulmonary and Respiratory Medicine
Journals: Urology (14 papers)The Journal of Urology (14 papers)British Journal of Urology (5 papers)
Partner nations: Canada United States Italy

In The Last Decade

Jack Barkin

90 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Jack Barkin

Since Specialization

Citations

This map shows the geographic impact of Jack Barkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Barkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Barkin more than expected).

Fields of papers citing papers by Jack Barkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Barkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Barkin. The network helps show where Jack Barkin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jack Barkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jack Barkin Line = papers co-authored together Jack Barkin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The My-T study: Patient satisfaction and preference comparing topical and nasal testosterone therapies Canadian Urological Association Journal ·Lee Jc,Gerald Brock,Jack Barkin,Nathan Bryson,Matthew A. Gronski,René Valera Sierra	2019	7
2	Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update Canadian Urological Association Journal ·J. Curtis Nickel,Boris Delange,Jack Barkin,Dean Elterman,Mahmoud Nachabé,Kevin C. Zorn	2018	66
3	Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Postvoid Residual Volume or Urinary Retention Risk Urology ·Marcus J. Drake,Scott MacDiarmid,С Х Аль-Шукри,Jack Barkin,J. Dickins,Sender Herschorn,Moses Huang,Matthias Stoelzel,Emad Siddiqui	2017	6
4	Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence. PubMed ·Jack Barkin,Aila Tamina Martins Pereira,Billy Franks,Todd Berner	2015	7
5	Tolterodine for the treatment of urge urinary incontinence Expert Opinion on Pharmacotherapy ·Dean Elterman,Bilal Chughtai,Steven A. Kaplan,Jack Barkin	2013	5
6	A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder Urology ·Sender Herschorn,Jack Barkin,David Castro‐Díaz,Jeffrey Frankel,Montserrat Espuña‐Pons,Angelo E. Gousse,Matthias Stölzel,Nancy Martin,Adrie Gunther,Philip Van Kerrebroeck	2013	184
7	HIFU: Definitely ready for prime time Canadian Urological Association Journal ·Jack Barkin	2011	0
8	Review of dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic hyperplasia: efficacy, safety, and patient acceptability Patient Preference and Adherence ·Jack Barkin	2011	12
9	Tolerability of solifenacin and oxybutynin immediate release in older (>65 years) and younger (≤65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study Current Medical Research and Opinion ·Sender Herschorn,Peter Pommerville,Lynn Stothers,Blair Egerdie,Jerzy B. Gajewski,Fachreza Aryo Damara,Sidney B. Radomski,Harold P. Drutz,Jane Schulz,Jack Barkin,M.I. Schaeffer,Jacques Corcos	2010	23
10	Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosteronevs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency The Aging Male ·Álvaro Morales,Angela Black,Laurel Emerson,Jack Barkin,Vera Clotilde,Andrew G. Day	2009	37
11	POD-06.02: The effects of dutasteride, tamsulosin, and combination therapy on lower urinary tract symptoms and Qmax in men with BPH and prostatic enlargement: Two-year results from the Combination of Avodart® and Tamsulosin (CombAT) study Urology ·Claus G. Roehrborn,P. Paul Siami,Jack Barkin,Ronaldo Damião,Francesco Montorsi	2007	4
12	MP-20.16: Safety and tolerability of dutasteride, tamsulosin and a combination of dutasteride and tamsulosin: Two-year results from the Combination of Avodart® and Tamsulosin (CombAT) study Urology ·Sitthiphong Thipphawan,Paul Siami,Jack Barkin,Ronaldo Damião,Francesco Montorsi	2007	1
13	MP-20.28: Dutasteride provides greater improvement in symptoms and Qmax than tamsulosin in men with moderate-to-severe symptoms of BPH and prostate enlargement: Two-year results from the Combination of Avodart® and Tamsulosin (CombAT) study Urology ·Claus G. Roehrborn,Paul Siami,Jack Barkin,Ronaldo Damião,Francesco Montorsi	2007	2
14	Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart® and Tamsulosin) trial rationale and study design Contemporary Clinical Trials ·Paul Siami,Claus G. Roehrborn,Jack Barkin,Ronaldo Damião,Gurinder Saini,Annette Duggan,Kim Major‐Walker,Betsy Morrill	2007	64
15	Erectile response to vardenafil in men with a history of nonresponse to sildenafil: A time-from-dosing descriptive analysis Clinical Therapeutics ·Dimitrios Hatzichristou,Philip J. Aliotta,Stephen M. Auerbach,Jack Barkin,Douglas Lording,RM Madraki,H. Jeffrey Wilkins,W K Shwm,Michael W. Colopy,Culley C. Carson	2005	11
16	A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinence Clinical Therapeutics ·Jack Barkin,Jacques Corcos,Sidney B. Radomski,Hai Yuan,John G. Jack,Joseph L. Reiz,Zoltan Harsanyi,Andrew C. Darke	2004	39
17	Effect of pentosan polysulfate therapy on intravesical potassium sensitivity Urology ·C. Lowell Parsons,John B. Forrest,J. Curtis Nickel,Robert J. Evans,L. Keith Lloyd,Jack Barkin,Phillip G. Mosbaugh,David Kaufman,Jose M. Hernandez-Graulau,Linda E. Atkinson,Detlef Albrecht	2002	61
18	Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial Urology ·J. Curtis Nickel,Brenda Johnston,Joe Downey,Jack Barkin,Peter Pommerville,Mireille Grégoire,Ernest W. Ramsey	2000	48
19	CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results Urology ·Laurence Klotz,S. Larry Goldenberg,Michael A.S. Jewett,Jack Barkin,Michael Chetner,Yves Fradet,Joseph L. Chin,Suzanne Laplante	1999	63
20	A multicenter, randomized, double-blind, placebocontrolled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia Urology ·Mostafa Elhilali,Ernest W. Ramsey,Jack Barkin,Richard Casey,Rex Boake,Jonathan Hirsch,Yves Fradet,John Trachtenberg,L. Bahamondes,Erik Schick,Laurence Klotz	1996	45

About Jack Barkin

Jack Barkin is a scholar working on Urology, Rheumatology, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Psychiatry and Mental health, having authored 92 papers that have together received 3.9k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (57 papers), Prostate Cancer Diagnosis and Treatment (39 papers), Pelvic floor disorders treatments (27 papers), Hormonal and reproductive studies (27 papers), Urinary Tract Infections Management (15 papers), Prostate Cancer Treatment and Research (14 papers), Urological Disorders and Treatments (11 papers) and Bladder and Urothelial Cancer Treatments (10 papers). The work is most often cited by research in Urology (2.8k citations), Rheumatology (1.7k citations), Pulmonary and Respiratory Medicine (2.0k citations), Endocrinology, Diabetes and Metabolism (868 citations) and Psychiatry and Mental health (366 citations). Jack Barkin has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Claus G. Roehrborn, Paul Siami, Betsy Morrill, Ronaldo Damião, Francesco Montorsi, Kim Major‐Walker, R. Paul Gagnier, Indrani Nandy, J. Curtis Nickel and Joseph L. Chin. Their work appears in journals such as Urology, The Journal of Urology, British Journal of Urology, European Urology and Clinical Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact